Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

See all formats and pricing
Volume 49, Issue 3 (Mar 2011)


Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease

David Prvulovic
  • Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University of Frankfurt, Frankfurt, Germany
/ Harald Hampel
  • Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University of Frankfurt, Frankfurt, Germany
  • Email:
Published Online: 2011-02-23 | DOI: https://doi.org/10.1515/CCLM.2011.087


A growing body of evidence suggests that Alzheimer's disease (AD) is a multifactorial disease resulting in the well-known, common neuropathological pathway characterized by extracellular fibrillar β amyloid (Aβ) deposits in the brain, intracellular neurofibrillary tangles (NFT) and neuronal as well as axonal degeneration. While fairly accurate, the clinical diagnosis of probable AD based on standard diagnostic criteria does not take into account the long preclinical and prodromal course of AD. AD-related pathophysiological changes can occur many years and even decades before the appearance of clinical dementia syndrome. Biomarkers that are related to the pathophysiology of AD may thus help detect the preclinical stages of disease, and improve early and differential diagnosis. Here, we provide an overview of current literature on the core AD biomarkers, Aβ and phosphor-tau (p-tau), on different methods and modalities of assessing them [e.g., cerebrospinal fluid (CSF) analysis and PET imaging], and on their diagnostic and predictive value in preclinical and clinical stages of AD.

Keywords: Alzheimer's disease; beta amyloid; intracellular neurofibrillary tangles; neuropathological pathway; p-tau

About the article

Corresponding author: Harald Hampel, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University of Frankfurt, Heinrich-Hoffmann-Str. 10, 60528 Frankfurt, Germany Phone: +49 (0)69 6301 6373, Fax: +49 (0)69 6301 87303

Received: 2010-11-11

Accepted: 2011-01-19

Published Online: 2011-02-23

Published in Print: 2011-03-01

Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2011.087. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Guruswami SM Sundaram, Dhruva Dhavale, Julie L Prior, Jothilingam Sivapackiam, Richard Laforest, Paul Kotzbauer, and Vijay Sharma
EJNMMI Research, 2015, Volume 5, Number 1
Wei Tang, Qiong Huang, Yan Wang, Zheng-Yu Wang, and Yu-You Yao
Journal of the Neurological Sciences, 2014, Volume 345, Number 1-2, Page 26
A. M. Fagan, C. Xiong, M. S. Jasielec, R. J. Bateman, A. M. Goate, T. L. S. Benzinger, B. Ghetti, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, S. Salloway, P. R. Schofield, R. A. Sperling, D. Marcus, N. J. Cairns, V. D. Buckles, J. H. Ladenson, J. C. Morris, and D. M. Holtzman
Science Translational Medicine, 2014, Volume 6, Number 226, Page 226ra30
Joanna L. Richens, Kevin Morgan, and Paul O'Shea
Neurobiology of Aging, 2014, Volume 35, Number 9, Page 2029
Fangli Liu, Zhenfei Xue, Ning Li, Hui Huang, Yanyan Ying, Jin Li, Lin Wang, and Wenjie Li
Journal of Trace Elements in Medicine and Biology, 2014, Volume 28, Number 2, Page 227
Brian J. Balin and Alan P. Hudson
Current Allergy and Asthma Reports, 2014, Volume 14, Number 3
Simone Lista, Francesco G. Garaci, Michael Ewers, Stefan Teipel, Henrik Zetterberg, Kaj Blennow, and Harald Hampel
Alzheimer's & Dementia, 2014, Volume 10, Number 3, Page 381
Annapaola Prestia, Anna Caroli, Karl Herholz, Eric Reiman, Kewei Chen, William J. Jagust, and Giovanni B. Frisoni
Alzheimer's & Dementia, 2013, Volume 9, Number 6, Page 677
Kristen E. Funk and Jeff Kuret
International Journal of Alzheimer's Disease, 2012, Volume 2012, Page 1
Simone Lista, Frank Faltraco, David Prvulovic, and Harald Hampel
Progress in Neurobiology, 2013, Volume 101-102, Page 1
Jon B. Toledo, Johannes Brettschneider, Murray Grossman, Steven E. Arnold, William T. Hu, Sharon X. Xie, Virginia M.-Y. Lee, Leslie M. Shaw, and John Q. Trojanowski
Acta Neuropathologica, 2012, Volume 124, Number 1, Page 23
Hong I Wan, Holly Soares, and Jeffrey F Waring
Biomarkers in Medicine, 2012, Volume 6, Number 1, Page 119
Balázs Gulyás, Christian Spenger, Zsuzsa Beliczai, Károly Gulya, Péter Kása, Mahabuba Jahan, Zhisheng Jia, Urs Weber, Andrea Pfeifer, Andreas Muhs, Dieter Willbold, and Christer Halldin
Neurochemistry International, 2012, Volume 60, Number 2, Page 153
Philip Seeman and Neil Seeman
Synapse, 2011, Volume 65, Number 12, Page 1289

Comments (0)

Please log in or register to comment.
Log in